Eiko LifeSciences Limited share price
BSE: EIKO
Key numbers
- Market cap
- ₹ 75.0 Cr
- Current price
- ₹ 51.22
- 52-week high / low
- ₹ 64 / 43
- Stock P/E
- 15.6
- Book value
- ₹ 47.9
- Dividend yield
- 0.00%
- ROCE
- 11.2%
- ROE
- 7.2%
- Debt to equity
- 0.07
- Sales growth (3 yrs)
- 36.2%
- Profit growth (3 yrs)
- 80.1%
- 1-year return
- -8.3%
About Eiko LifeSciences Limited
Eiko LifeSciences Limited, together with its subsidiary, manufactures and supplies specialty chemicals, fine chemicals, and active pharmaceutical ingredients in India and internationally. It offers speciality chemicals and intermediates, such as lasamide, trichloro salicylic acid, chloroacetyl xylidide, and thiodipropionic acid; agrochemical intermediates; and cosmetic emollients, including isopropyl oleate, isopropyl palmitate, methyl myristate, butyl laurate, isopropyl laurate, isopropyl myristate, butyl oleate, methyl myristate, and methyl laurate. The company also provides APIs comprising topiramate, glcosamine HCL/sodium/potassium, minoxidil sulfate, phenylephrine HCL, tamsulosin, nebivolol, lidocaine, minoxidil, furosemide, flurbiprofen, and meloxicam; and flavor and fragrances consisting of coumarin, dihydrocoumarin, benzyl acetone, methyl anthranilate, anisyl acetone, and benzylidine acetone, as well as phenyl ethyl allyl ether, phenyl propyl alcohol, and phenyl ethyl isoamyl ether. In addition, it exports its products. The company was formerly known as Narendra Investments (Delhi) Limited and changed its name to Eiko LifeSciences Limited in June 2021. Eiko LifeSciences…
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 11 | 12 | 12 | 18 | 17 |
| Operating profit | 2 | 2 | 2 | 2 | 2 |
| Net profit | 1 | 1 | 1 | 1 | 1 |
| EPS (₹) | 0.66 | 0.78 | 0.88 | 0.93 | 0.91 |
Peers in Specialty Chemicals
Data for information only, not investment advice. Prices end of day.